Roche
Search results
Genentech's legacy and future aspirations are built on the belief that the boundaries of science are meant to be broken and that we can solve some of the hardest biomedical challenges plaguing humankind. Learn More. Quick Links. Advancing Inclusive Research. Patient Financial Support.
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. Historically, the company is regarded as the world's first biotechnology company.
Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for more than 45 years. Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.
Genentech is a leading biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Its transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
Genentech has multiple medicines for serious and life-threatening medical conditions. Access information and resources on each of our medicines.
Genentech | 749,830 followers on LinkedIn. About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting...
Genentech is committed to defeating cancer. Building upon our legacy as pioneers in oncology, we're boldly innovating beyond the science and envision a better future for every cancer patient, caregiver, and provider. We can't do it alone.
Sep 22, 2023 · As healthcare gets ever more personalized, Genentech is expanding innovation from the lab into marketing, in service of “science for good.” The biotech pioneer’s chief marketing officer tells how.
A leading healthcare company dedicated to innovation in a sustainable way. 1896. Founded in Basel, family still holds majority stake. 62.8 bn. Sales 2021 (CHF) Genentech1, first publicly-owned. Biotech. ♯1. R&D investor in healthcare.
Feb 13, 2023 · Genentech is spending $450 million on a California plant, where it aims to move medicines from production to patients “faster and more sustainably.”
